Cross-sectional
|
Ekelund11
|
Europe |
2006 |
9 to 10 15 to 16 |
1921 (1010/911) |
TV |
Questionnaire |
BF, HDL-C, TG, Insulin, Glucose, SBP, DBP, and CR |
S |
Sardinha12
|
Portugal |
2008 |
9 to 10 |
308 (147/161) |
TS |
Accelerometry |
HOMA-IR |
N |
Torres13
|
Spain |
2008 |
3 to 13 |
373 (169/204) |
Screen |
Questionnaire |
BMI |
N |
Wells14
|
Brazil |
2008 |
10 to 12 |
4452 (2258/2193) |
TV |
Questionnaire |
BMI, BF, SBP, and DBP |
S |
Martinez-Gomez15
|
USA |
2009 |
3 to 8 |
111 (54/57) |
TS, Screen, TV, CP |
Accelerometry Questionnaire |
SBP and DBP |
N |
Hardy16
|
Australia |
2010 |
14 to 17 |
496 (206/290) |
Screen |
Questionnaire |
HDL-C, LDL-C, TG, Insulin, Glucose, HOMA-IR, SBP, and DBP |
N |
Kang17
|
Korea |
2010 |
10 to 18 |
845 (396/449) |
Screen |
Questionnaire |
SM |
N |
Martinez-Gómez18
|
Spain |
2010 |
13 to 17 |
201 (99/102) |
TS |
Accelerometry |
BMI, BF, WC, TC, HDL-C, LDL-C, TG, Glucose, SBP, DBP, and CR |
N |
McCrindle19
|
Canada |
2010 |
14 to 15 |
20719 (10300/10419) |
TV+VG, CP |
Questionnaire |
BMI, TC, SBP, DBP, and CR |
N |
Rivera20
|
Brazil |
2010 |
7 to 17 |
1253 (706/547) |
TV |
Questionnaire |
BMI and BF |
N |
Alvarez Caro21
|
Spain |
2011 |
6 to 12 |
459 (213/246) |
TS, TV+VG, CP |
Questionnaire |
BMI |
N |
Carson22
|
EUA |
2011 |
6 to 19 |
2527 (1243/1284) |
TS, Bout, Breaks, TV, CP |
Accelerometry Questionnaire |
WC, non-HDL, SBP, and CR |
S |
Danielsen23
|
Norway |
2011 |
7 to 13 |
86 (38/48) |
Screen |
Questionnaire |
TC, HDL-C, LDL-C, TG, and HOMA-IR |
S |
Goldfield24
|
Canada |
2011 |
14 to 18 |
282 (196/86) |
Screen, TV, VG, CP |
Questionnaire |
WC, HDL-C, LDL-C, TG, CTC/HDL-C, SBP, and DBP |
S |
Hsu25
|
US |
2011 |
13 |
105 (79/26) |
TS, Screen |
Accelerometry Questionnaire |
WC, HDL-C, TG, Glucose, SBP, DBP, and MS |
N |
Lehto26
|
Finland |
2011 |
9 to 11 |
604 (312/292) |
TV, CP+VG |
Questionnaire |
WC and WHR |
S |
Altenburg27
|
Netherlands |
2012 |
12 to 18 |
125 (71/54) |
Screen, TV, CP |
Questionnaire |
BMI, GC, TC, HDL-C, LDL-C, TG, Insulin, Glucose, SBP, DBP, and CR |
S |
Byun28
|
Korea |
2012 |
12 to 18 |
577 (261/316) |
Screen, TV, CP+VG |
Questionnaire |
BMI, WC, TC, HDL-C, LDL-C, TG, SBP, and DBP |
S |
Martinez-Gomez29
|
Spain |
2012 |
13 to 17 |
181 (88/93) |
CP, VG |
Questionnaire |
WC, TC, HDL-C, LDL-C, TG, Insulin, Glucose, SBP, SBP, MBP, and CR |
S |
Camhi30
|
US |
2013 |
12 to 18 |
225 (118/107) |
Screen, TV, CP |
Questionnaire |
CR |
N |
Chaput31
|
Canada |
2013 |
8 to 10 |
536 (244/292) |
TS, Screen |
Accelerometry Questionnaire |
WC, HDL-C, TG, Glucose, SBP, and DBP |
S |
Colley32
|
Canada |
2013 |
6 to 19 |
1608 (799/809) |
TS, Bout, Breaks |
Accelerometry |
BMI, WC, non-HDL, SBP, and DBP |
S |
Govindan33
|
US |
2013 |
10 to 12 |
1714 (906/808) |
TV, CP, VG |
Questionnaire |
BMI |
N |
Rey-Lopez34
|
Europe |
2013 |
12 to 17 |
769 (393/376) |
TV, VG |
Questionnaire |
CR |
S |
Saunders35
|
Canada |
2013 |
8 to 11 |
522 (236/286) |
TS, Bout, Breaks, TV, CP+VG |
Accelerometry Questionnaire |
BMI, WC, HDL-C, TG, Insulin, Glucose, and CR |
S |
Sisson36
|
US |
2013 |
12 to 20 |
394 (193/201) |
TS |
Questionnaire |
BMI, WC, HDL-C, TG, Insulin, Glucose, HOMA-IR, MBP, CR, and MS |
S |
Stamatakis37
|
Portugal |
2013 |
2 to 12 |
2515 (1427/1088) |
TV, CP, VG |
Questionnaire |
SBP, DBP, and CR |
Y |
Berentzen38
|
Netherlands |
2014 |
11 to 14 |
1447 (744/703) |
Screen, TV, CP |
Questionnaire |
BMI, WC, WHR, TC/HDL-C, SBP, and DBP |
N |
Chinapaw39
|
Netherlands |
2014 |
5 to 6 |
1961 (961/1000) |
TV, CP+VG |
Questionnaire |
WC, HDL-C, LDL-C, TG, Glucose, MBP, and CR |
Y |
Cliff40
|
Australia |
2014 |
5 to 9 |
120 (74/46) |
TS, Bout |
Accelerometry |
HDL, TG, Insulin, Glucose, SBP, DBP, CR |
Y |
Crispim41
|
Brazil |
2014 |
2 to 5 |
276 (131/145) |
TV |
Questionnaire |
SBP and DBP |
N |
Flynn42
|
EUA |
2014 |
10 to 12 |
1104 (565/539) |
Screen |
Questionnaire |
HDL-C |
N |
Väistö43
|
Finland |
2014 |
6 to 8 |
468 (225/243) |
TS, Screen, TV |
Questionnaire |
BF, WC, TC, HDL-C, LDL-C, VLDL-C, TG, Insulin, Glucose, SBP, DBP, and CR |
Y |
do Prado Junior44
|
Brazil |
2015 |
10 to 19 |
676 (378/298) |
Screen |
Questionnaire |
TC, LDL-C, HDL-C, TG, SBP, and DBP |
N |
Herman45
|
Canada |
2015 |
8 to 10 |
534 (248/286) |
TS, Screen, TV |
Accelerometry Questionnaire |
BMI and WC |
N |
Rendo-Urteaga46
|
Europe |
2015 |
12 to 17 |
769 (404/365) |
Screen |
Questionnaire |
BF, TC/HDL-C, TG, HOMA-IR, SBP, and CR |
N |
Robinson47
|
Australia |
2015 |
7 to 10 |
264 |
TV, CP, VG, Screen |
Questionnaire |
BMI, WC, TC, HDL-C, LDL-C, TG, SBP, DBP, and CR |
Y |
Safiri48
|
Iran |
2015 |
10 to 18 |
5625 (2801/2824) |
TV, CP, Scree |
Questionnaire |
BMI, WHR, TC, HDL-C, LDL-C, TG, Glucose, SBP, DBP, and MS |
N |
Vaccaro49
|
US |
2016 |
6 to 12 |
614 |
Screen |
Questionnaire |
BMI |
N |
Batalau50
|
Portugal |
2017 |
7 to 10 |
77 (31/46) |
TS, Bout, Screen |
Accelerometry Questionnaire |
TC,HDL-C, LDL-C, TG, Glucose,SBP, and DBP |
N |
Katzmarzyk51
|
US |
2017 |
5 to 18 |
357 |
TV |
Questionnaire |
BMI, BF, WC, HDL-C, TG, Glucose, SBP, DBP, and CR |
Y |
Norman52
|
US |
2017 |
11 to 13 |
106 (54/52) |
TS, Screen |
Accelerometry Questionnaire |
BMI, GC, WC, HDL-C, LDL-C, TG, Insulin, Glucose, SBP, and DBP |
Y |
Hansen53
|
ICAD* |
2018 |
4 to 18 |
18200 (9207/8993) |
TS |
Accelerometry |
WC, HDL-C, LDL-C, TG, Insulin, Glucose, SBP |
N |
Cristi-Montero54
|
Europe |
2019 |
12 to 17 |
548 (289/259) |
TS |
Accelerometry |
BF, TC/HDL-C, TG, HOMA-IR, SBP, and CR |
Y |
Longitudinal
|
de Moraes55
|
Europe |
2015 |
2 to 9 |
5061 (2576/2485) |
Screen |
Questionnaire |
SBP and DBP |
N |
Stamatakis56
|
England |
2015 |
11 to 12 |
4639 (2459/2180) |
TS |
Accelerometry |
BMI, BF, WC, TC, HDL-C, LDL-C, TG, Insulin, Glucose, SBP, DBP, and CR |
Y |
Norman52
|
US |
2017 |
11 to 13 |
106 (54/52) |
TS, Screen |
Accelerometry Questionnaire |
IMC, GC, PC, HDL, LDL, TG, Insulin, Glucose, PAS e PAD |
Y |
Skrede57
|
Norway |
2017 |
10 |
700 (356/344) |
S |
Accelerometry |
WC, TC/HDL-C, TG, HOMA-IR, SBP, and CR |
N |
Väistö58
|
Finland |
2019 |
6 to 8 |
258 (140/118) |
TS |
Accelerometry |
BF, WC, HDL-C, LDL-C, TG, Insulin, Glucose, HOMA-IR, SBP, DBP, and CR |
N |
Randomized
|
Saunders59
|
Canada |
2013 |
10 to 14 |
19 (8/11) |
Breaks |
Observation |
HDL-C, LDL-C, TG, Insulin, and Glucose |
Y |
Belcher60
|
USA |
2015 |
7 to 11 |
28 (15/13) |
Breaks |
Observation |
TG, Insulin, and Glucose |
N |